Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 1801 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 1802 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 30,8 |
| 1803 | Cord Tissue | Allogeneic – Unrelated | Thermal Injury | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1804 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1805 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1806 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1807 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1808 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1809 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1810 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1811 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 1812 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1813 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1814 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1815 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1816 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 1817 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 1818 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 1819 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 1820 | Cord Tissue | Allogeneic – Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 1821 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5,8 |
| 1822 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9,7 |
| 1823 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7 |
| 1824 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 1825 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 3,9 |
| 1826 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 5,2 |
| 1827 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 1828 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2021 | Experimental Therapy | Germany | 8 |
| 1829 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 9 |
| 1830 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 1831 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 6 |
| 1832 | Cord Blood | Allogeneic – Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 |
| 1833 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6 |
| 1834 | Cord Blood | Allogeneic – Related | Diamond Blackfan Anemia | Hematology | 2021 | Standard Therapy | Turkey | 3,12 |
| 1835 | Cord Blood | Autologous | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Germany | 7 |
| 1836 | Cord Blood | Allogeneic – Related | Immune Failure-Cd40 L Deficiency | Hematology | 2021 | Standard Therapy | Turkey | 12,4 |
| 1837 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 5,6 |
| 1838 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16,6 |
| 1839 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 7,3 |
| 1840 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
| 1841 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 1842 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 33 |
| 1843 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 1844 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 1845 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 1846 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 1847 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 1848 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 1849 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 1850 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 1851 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 1852 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 1853 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 1854 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 1855 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 1856 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 1857 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 1858 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
| 1859 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 1860 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 36 |
| 1861 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 39 |
| 1862 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 71 |
| 1863 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 1864 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 1865 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 1866 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 1867 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 1868 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 1869 | Bone Marrow Family | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 1870 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1871 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 1872 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 1873 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1874 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 1875 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1876 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 1877 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 1878 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 1879 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1880 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 1881 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 1882 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 1883 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 1884 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1885 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 1886 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1887 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 1888 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 1889 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 1890 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 15 |
| 1891 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 1892 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2021 | Standard Therapy | Poland | 8 |
| 1893 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 1894 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 1895 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
| 1896 | Bone Marrow | Allogeneic | Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 1897 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 16 |
| 1898 | Bone Marrow | Allogeneic | Bcr-Abl Pos. All | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 1899 | Bone Marrow | Allogeneic | Beta Thalassemia Major | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 1900 | Bone Marrow | Allogeneic | Cartilage Hair Hypoplasia | Hematology | 2021 | Standard Therapy | Poland | 7 |